YEZTUGO is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in
adults and adolescents who are at risk for HIV-1. Individuals must have a negative HIV-1
test prior to initiating YEZTUGO.

Join fellow nurse practitioners from across Pennsylvania for the PCNP 22nd Annual Conference, taking place Nov. 13 -15, 2025, at the Kalahari Convention Center in Pocono Manor, PA.